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Abstract
Background
We sought to summarize Computed Tomography (CT)/Magnetic Resonance Imaging (MRI)
features of intracerebral hemorrhage (ICH) associated with cerebral amyloid angiopathy
(CAA) in published observational radio-pathological studies.
Methods
In November 2016, two authors searched OVID Medline (1946-), Embase (1974-) and rele-
vant bibliographies for studies of imaging features of lobar or cerebellar ICH with patholog-
ically proven CAA (“CAA-associated ICH”). Two authors assessed studies’ diagnostic test
accuracy methodology and independently extracted data.
Results
We identified 22 studies (21 cases series and one cross-sectional study with controls) of CT
features in 297 adults, two cross-sectional studies of MRI features in 81 adults and one
study which reported both CT and MRI features in 22 adults. Methods of CAA assessment
varied, and rating of imaging features was not masked to pathology. The most frequently
reported CT features of CAA-associated ICH in 21 case series were: subarachnoid exten-
sion (pooled proportion 82%, 95% CI 69–93%, I2 = 51%, 12 studies) and an irregular ICH
border (64%, 95% CI 32–91%, I2 = 85%, five studies). CAA-associated ICH was more likely
to be multiple on CT than non-CAA ICH in one cross-sectional study (CAA-associated ICH
7/41 vs. non-CAA ICH 0/42; χ2 = 7.8, p = 0.005). Superficial siderosis on MRI was present in
52% of CAA-associated ICH (95% CI 39–65%, I2 = 35%, 3 studies).
Conclusions
Subarachnoid extension and an irregular ICH border are common imaging features of CAA-
associated ICH, but methodologically rigorous diagnostic test accuracy studies are required
to determine the sensitivity and specificity of these features.
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Introduction
About 85% of ‘primary’ intracerebral haemorrhages (ICHs) have no specific underlying cause
and are attributed to cerebral small vessel diseases, mostly arteriolosclerosis or cerebral amy-
loid angiopathy (CAA).[1,2] Arteriolosclerosis may underlie ICH in any location, whereas
CAA only affects cortical and leptomeningeal vessels and is therefore associated with lobar
and cerebellar ICH.[3] Accurate diagnosis of lobar or cerebellar ICH accompanied by patho-
logically-proven CAA (“CAA-associated ICH”) is important given its higher risk of recurrent
ICH, anticoagulant-associated ICH and post-stroke dementia compared with arteriolosclero-
sis-associated ICH.[2,4]
Whilst definitive diagnosis of CAA requires histopathology, tissue samples from living
patients are rarely available. In contrast, brain imaging is commonly performed in ICH, and
may help differentiate these underlying pathologies. The magnetic resonance imaging
(MRI)-based modified Boston criteria attribute lobar or cerebellar ICH to ‘probable CAA’
without pathological confirmation if there is either at least one other lobar or cerebellar ICH
on brain imaging, or if at least one lobar cerebral or cerebellar microbleed or cortical superfi-
cial siderosis is present on gradient-echo brain MRI sequences.[5,6] The criteria have excel-
lent sensitivity (95%, 95% CI 83–99%) and good specificity (81%, 95% CI 62–93%) in a
hospital-based cohort with ICH,[5] but have not been externally validated. Positron
emission tomography (PET) can directly detect amyloid ante-mortem. Whilst it shows good
sensitivity (92%, 95% CI 72–99%) for presumed CAA-associated lobar ICH, its specificity is
limited (65%, 95% CI 50–78%), reflecting the high frequency of parenchymal amyloid pla-
ques among the healthy elderly.[7] Another drawback of MRI- and PET-based diagnostic
criteria for CAA-associated ICH is the limited access to advanced imaging; these techniques
may not be suitable in the acute setting, nor available, particularly in middle and low-income
countries, where 75% of deaths from haemorrhagic stroke now occur.[8] In contrast, com-
puted tomography (CT) is widely available, has few contraindications and is frequently
used as the first test to investigate stroke. Therefore determining whether any CT features of
ICH and the rest of the brain discriminate between CAA-associated ICH and other ICH is
important.
The primary objective of this study was to systematically review and meta-analyse published
diagnostic test accuracy studies or other observational radio-pathological studies describing
features of CAA-associated lobar or cerebellar ICH.
Materials and methods
Search strategy and selection criteria
In November 2016 two authors (NS and PST) searched Ovid Medline (1946-) and Embase
(1974-) using comprehensive electronic search strategies (S1 Appendix). One author (PST)
also searched the bibliographies of relevant publications and Google scholar for other papers
citing each included paper. We also searched our personal files. We did not publish a review
protocol. We performed the study according to the PRISMA statement (S1 Checklist).[9]
Eligibility criteria
Published studies were eligible for inclusion if they described imaging features of lobar or cere-
bellar ICH associated with CAA, proven pathologically by brain biopsy, haematoma evacua-
tion or post-mortem (primary outcome), regardless of sample size, language of publication,
and study design.
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Data collection
Two authors (NS and PST) screened all titles and abstracts for eligibility, removed duplicates
and read the full text of articles that were potentially eligible for inclusion. Eligible studies were
read in full by two authors (NS and PST) who extracted data independently on: study design,
methods of assessment and grading of CAA, participant characteristics and imaging features
of ICH. We resolved disagreements by discussion. If pertinent study attributes or data were
unavailable or unclear in an eligible publication, we sought clarification from the authors by
email.
Methodological assessment
Two authors (NS and PST) assessed each study using three items from the Joanna Briggs Criti-
cal Appraisal checklist for descriptive studies and case seriess1 (sample selection, definition of
inclusion criteria, and identification of confounding factors [in particular patient age and
dementia]) in addition to assessing whether rating of imaging features was blinded to patho-
logical findings and vice versa. For cross-sectional studies, we applied the QUADAS-2 tool
which judges the quality of diagnostic test accuracy studies based upon patient selection, the
index test, reference standard and participant flow through the study.s2
Statistical analysis
If we identified multiple publications relating to the same cohort, we included only the largest
study. For each case-series study, we determined the numbers of participants with lobar or cer-
ebellar ICH accompanied by pathologically-proven CAA anywhere in the brain (“CAA-associ-
ated ICH”) and the frequency of the reported imaging characteristics of these participants’
brains. NS used the Stata command ‘metaprop’ to assess the prevalence of each imaging char-
acteristic in CAA-associated ICH as a pooled proportion in a random-effects model with com-
putation of confidence intervals using the ‘score’ method (Stata version 11.1, StataCorp LP,
College Station, USA). NS assessed inconsistency using the I2 statistic. We sought to stratify
our analyses by pre-ICH history of hypertension (present or not), first-ever vs. recurrent ICH
and supratentorial lobar versus cerebellar ICH. We also assessed the frequency of reported
combinations of imaging characteristics of CAA-associated ICH.
Results
Our search strategies identified 1,715 articles of which 22 (one cross-sectional study with con-
trols [10] and 21 case series without controls [11–31]) described CT features of CAA-associ-
ated lobar or cerebellar ICH in 297 adults, two studies described MRI features [5,32] in 81
adults and one cross-sectional study [33] described both CT and MRI features in 22 adults (Fig
1). There were no PET studies. We excluded one hospital-based cross-sectional studys3 which
did not report ICH location per participant and whose applicability to this review raised con-
cern because of the age (mean 58 years; standard deviation 11) and haematoma locations (185/
421 [44%] in the basal ganglia) of those with CAA-associated ICH.
Methodological quality of included studies
All 21 case series were hospital-based, using either consecutive cases in three (14%) studies
[13,18,20] or selected hospital cases in the remainder, with a median sample size of 14 (IQR
7–37) (Table 1). Nine (43%) stated inclusion criteria.[11,13–15,17–21] Studies were retrospec-
tive bar one that selected consecutive patients from a prospectively recruited cohort.[13]
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Of the two retrospective hospital-based cross-sectional studies using CT,[10,33] one
included 41 cases [10] and the other 22 cases.[33] Both had a high risk of bias owing to inclu-
sion of selected cases, potential misclassification since not all participants received the same
reference standard and an unknown time interval between the index test (brain imaging)
and the reference standard (histopathological diagnosis). The two cross-sectional studies
assessing solely MRI were both retrospective hospital-based studies.[5,32] Again there was risk
of bias due to potential misclassification since not all participants received the same reference
standard.
Nine (36%) studies [15,17,19,21,24,25,27,30,31] distinguished first-ever from recurrent
ICH. A pre-ICH history of hypertension or dementia were described in 19 (76%) [12,14–
19,21–29,31–33] and 14 (56%) studies [11,12,14,15,17,19,22,25,27–31] respectively. Only four
(16%) studies stated the interval between symptom onset and the diagnostic scan [20,22,23,31]
and six (24%) studies stated the interval between the diagnostic scan and post-mortem or
biopsy.[19–21,24,29,32] The number of raters of radiological features was mentioned in only
four (16%) studies,[5,10,13,33] three of which used at least two raters per case.[5,10,13] Dis-
agreements were resolved by consensus in two of these,[5,13] whilst the other study did not
specify this.[10]
Pathological assessment. The extent of brain sampling for CAA varied considerably
between the studies (Table 2). All studies bar two (which did not state how the authors
Fig 1. Flowchart of studies.
https://doi.org/10.1371/journal.pone.0180923.g001
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Table 2. Pathology assessment in included studies.
Study (Year) Number of
tissue
blocks
examined
CAA sampling:
Post-mortem/
biopsy/ICH
evacuation
Locations
examined in
cases
CAA
detection
Rating of
severity of
CAA
Number of
raters of
CAA
Doden
(2016)[33]
? 0/?/? Haematoma site CR &IHC Presence/
Absence
?
Hirohata
(2010)[11]
? 9/32/0 ? CR & IHCa Presence/
Absence
?
Panicker
(2010)[12]
? 1/2/0 ? CR Vonsattele4 ?
Patel (2009)
[13]
? 2/10/0 Haematoma
site, L
CR or IHC Presence/
Absence
1
Chen (2004)
[14]
? 0/5/0 Haematoma site CR Presence/
Absence
?
Oide (2003)
[15]
1 or 2 12/52/0 L CR & IHC Presence/
Absence
?
Lang (2001)
[10]
1 0/41/0 Haematoma site CR Presence/
Absence
?
Wang (2000)
[16]
? 0/2/0 Haematoma site CR Presence/
Absence
?
Izumihara
(1999)[17]
? 0/37/0 Haematoma site CR & IHC Presence/
Absence
?
Hagen
(1999)[18]
? 0/13/0 Haematoma site CR Presence/
Absence
?
Millar (1999)
[19]
? 5/0/0 ? ? Presence/
Absence
?
Minakawa
(1995)[20]
? 0/10/0 Haematoma site CR Presence/
Absence
?
Wakai (1992)
[21]
1 0/6/0 Haematoma site CR & if
+ve IHC
Presence/
Absence
?
Yong (1992)
[22]
? 0/6/0 Haematoma site CR & IHC Presence/
Absence
?
Xu (1990)
[23]
? 11/0/0 Haematoma site CR Presence/
Absence
?
Andoh (1989)
[24]
? 0/3/0 Haematoma site CR or IHC Presence/
Absence
?
Sobel (1985)
[25]
? 2/0/0 ? CR Presence/
Absence
?
Cosgrove
(1985)[26]
5 6/0/0 L, HC, BG, M, C CR Author’s own 1
Brown (1985)
[27]
? 7/5/0 ? CR Presence/
Absence
?
Gray (1985)
[28]
3 3/0/0 F, P-O,BG CR Presence/
Absence
?
Kalyan
Raman
(1984)[29]
11 4/2/0 F, T, P, O, C,
HC, BG, M,P,
Me,
Haematoma
CR,
Thioflavin
T
Presence/
Absence
?
Patel (1984)
[30]
1 0/2/0 ? CR Presence/
Absence
?
Wagle (1984)
[31]
? 5/2/0 ? CR Presence/
Absence
?
Charidimou
(2015)[32]
? ?/?/? ? CR or IHC Vonsattele4 ?
(Continued )
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ascertained CAA [5,19]) used Congo Red staining, nine of which also used immunohis-
tochemistry for all [15,17,22] or some cases.[11,13,21,24,32,33] Two studies described the
severity of CAA rather than its presence or absence.[12,26] None of the studies stated whether
CAA was rated blind to imaging findings or whether more than one rater rated CAA.
CT features of CAA-associated ICH
Characteristics of included participants in CT studies. The majority of ICHs in the 319
participants were supratentorial lobar (n = 313). Three had a cerebellar ICH, one ICH was
supratentorial lobar and cerebellum and two participants had a cerebellar ICH (but we could
not determine whether it had occurred in isolation).
Frequency of CT features of CAA-associated ICH. The most frequently reported imag-
ing features of CAA-associated ICH in case series without controls were: multiple simulta-
neous ICHs (19 studies), intraventricular extension of ICH (15 studies), subarachnoid
extension (14 studies) and an irregular ICH border (6 studies) (Table 3). The pooled propor-
tion of participants with subarachnoid extension was 82% (95% CI 69–93%, I2 = 51%, 12
studies), irregular ICH border 64% (95% CI 32–91%, I2 = 85%, 5 studies), intraventricular
hemorrhage 47% (95% CI 29%-65%, I2 = 76%, 14 studies) and multiple ICHs 37% (95% CI
18–58%, I2 = 75%, 14 studies), (Fig 2 and Table 3).
17 studies described the locations of 346 ICHs in 262 patients.[10–12,14,15,17,18,20,22–
27,29–31] The most frequent ICH locations were the frontal (83 [24%]) and parietal (83
[24%]) lobes. 72 (21%) ICHs were occipital, 58 (17%) were located in the temporal lobes and 7
(2%) were cerebellar. The remaining 43 ICHs involved multiple supratentorial lobes, with the
parieto-occipital (15 [4%]) and fronto-parietal (14 [4%]) regions being the most frequently
involved.
In one cross-sectional study,[10] CAA-associated ICHs were more likely to be multiple
(CAA-associated ICH 7/41 vs. non-CAA ICH 0/42; χ2 = 7.8, p = 0.005) and have subarachnoid
haemorrhage (CAA-associated ICH 26/41 vs. non-CAA ICH 11/42; p<0.05) compared to
non-CAA ICHs. CAA-associated ICHs were also more likely be lobulated in comparison to
non-CAA ICH (CAA-associated ICH 17/41 vs. non-CAA ICH 5/42; χ2 = 9.3, p = 0.002) but
the proportion of ICHs with an irregular border did not differ between groups (CAA-associ-
ated ICH 15/41 vs. non-CAA ICH 22/42; χ2 = 2.1, p>0.05). However, the study did not
explicitly define the terms ‘lobulated’ or ‘irregular border’. There was no difference in intra-
ventricular haemorrhage between groups (CAA-associated ICH 10/41 vs. non-CAA ICH 11/
Table 2. (Continued)
Study (Year) Number of
tissue
blocks
examined
CAA sampling:
Post-mortem/
biopsy/ICH
evacuation
Locations
examined in
cases
CAA
detection
Rating of
severity of
CAA
Number of
raters of
CAA
Linn (2010)
[5]
? ?/?/? ? ? ? ?
Locations: F = frontal lobe, P = parietal lobe, O = occipital lobe, P-O = Parieto-occipital region, T = temporal
lobe, L = lobar unspecified, C = cerebellum, CC = corpus callosum, BG = basal ganglia, HC = hippocampus,
M = midbrain, Me = medulla, Haematoma site = haematoma itself and/or adjacent parenchyma.
CAA = cerebral amyloid angiopathy, CR = Congo red stain, ICH = intracerebral haemorrhage,
IHC = immunohistochemistry,
?
= not reported,
a
-IHC in 23
https://doi.org/10.1371/journal.pone.0180923.t002
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42; p>0.05). In another cross-sectional study [33] there was no difference in either intraven-
tricular hemorrhage (CAA-associated ICH 14/22 vs. non-CAA ICH 4/9; p = 0.279) or focal
subarachnoid hemorrhage (CAA-associated ICH 11/22 vs. non-CAA ICH 2/9; p = 0.154)
between groups.
Fig 2. CT features of CAA-associated ICH–Pooled proportion meta-analysis, stratified by imaging
feature. ES = effect size with 95% confidence intervals, n = number of participants with feature, N = number of
participants with CAA-associated ICH.
https://doi.org/10.1371/journal.pone.0180923.g002
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CT features of CAA-associated ICH did not differ in first-ever vs recurrent ICH (S1 Fig) or
those with a history of pre-stroke hypertension vs. those without (S2 Fig). We were unable to
compare imaging features in lobar vs. cerebellar ICH given the paucity of infratentorial ICHs
(n = 6). In 11 studies [12,18–22,25,27–29,31] of 75 ICHs reporting imaging features for each
case of CAA-associated ICH, the three most frequently paired features were: intraventricular
and subarachnoid extension (n = 21 [28%]), an irregular ICH border with subarachnoid exten-
sion (n = 14 [19%]) and a blood or fluid level within the haematoma with subarachnoid exten-
sion (n = 12 [16%]).
MRI features of CAA-associated ICH
Characteristics of included studies and participants. We identified three retrospective,
hospital-based cross-sectional studies, one of CAA-associated ICH which fulfilled the Boston
criteria for CAA (we assumed CAA-associated ICH was either lobar or cerebellar [n = 27] vs.
non-CAA ICH [n = 22]),[5] one of CAA-associated lobar ICH (n = 54) vs CAA without ICH
(n = 51) [32] and a cross sectional study which used MRI on a subset of 17 adults with cortico-
subcortical (i.e. lobar) ICH which fulfilled the Boston criteria for CAA vs. non-CAA ICH
(n = 7).[33]
Frequency of MRI features of CAA-associated ICH. The pooled proportion of focal or
disseminated superficial siderosis in CAA-associated ICH was 52% (95% CI 39–65%, I2 = 35%,
3 studies; S3 Fig). The imaging features of ICH reported in one study were lobar brain micro-
bleeds (n = 36 [67%]), severe centrum semi-ovale enlarged perivascular spaces (n = 29 [55%]),
severe white matter hyperintensities (n = 13 [24%]) and severe basal ganglia enlarged perivas-
cular spaces (n = 11 [21%]).[32] We excluded one study from this analysis which used CT to
report white matter hyperintensities and did not report the frequency of lobar brain micro-
bleeds.[33]
None of the studies assessing MRI features of CAA-associated ICH described ICH
locations.
Sensitivity and specificity of the Boston criteria for detection of CAA-associated ICH.
From one study (n = 31) the sensitivity of the Boston criteria was 32% (95% CI 16–53%) and
the specificity was 78% (95% CI 45–94%), however 7/31 participants did not have MRI.[33]
Discussion
In this systematic review and meta-analysis of 25 radio-pathological studies of 400 adults with
CAA-associated lobar or cerebellar ICH, the most common CT imaging features in CAA-asso-
ciated ICH were extension of the ICH into the subarachnoid space and an irregular ICH bor-
der. We found no difference in these CT imaging features of CAA-associated ICH in people
with vs. without a pre-stroke history of hypertension and people with first-ever vs. recurrent
lobar ICH. Superficial siderosis on MRI was visible in more than half of those with CAA-asso-
ciated ICH.
This review benefited from comprehensive search strategies to ascertain relevant studies
and thorough critical appraisal of all identified studies by two independent authors. However,
study quality was limited, since most studies were hospital-based case series, which did not
report the interval between symptom onset and the diagnostic scan (which may affect the
imaging appearances of an ICH), had no blinding of assessors and lacked definitions of imag-
ing variables or CAA-associated ICH.
We demonstrated that subarachnoid extension was a frequent finding in CAA-associated
ICH, which may be in keeping with CAA preferentially affecting leptomeningeal and cortical
vessels which could rupture into the subarachnoid space.[34] However, this may also be due to
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the selection bias of pathological studies, since subarachnoid extension is associated with larger
ICH volumes,[35] or simply anatomy rather than underlying pathology since subarachnoid
extension is more frequent in lobar ICH compared to non-lobar ICH.[1]
CAA-associated ICHs frequently had an irregular border. Whilst the pathophysiology of
this finding is not fully understood, it may reflect deficiencies in endothelial and subendothe-
lial functioning in CAA-affected vessels and/or impaired vasoconstriction, resulting in detri-
mental effects on haemostasis.[10,36,37] Alternatively, selection bias in radio-pathological
studies may account for this finding since an irregular ICH border is associated with death.
[38]
Although we found no difference in imaging characteristics between people with first-ever
and recurrent ICH, the sample size was small. Multiple ICH was more frequent in CAA-asso-
ciated ICH in one cross-sectional study, and both multiple and recurrent ICH may be in keep-
ing with a biological gradient for CAA that is yet to be established.[3] Similarly we could not
detect a difference between people with pre-ICH hypertension and those without, although
this may be due to selection bias, variable definitions of hypertension, inclusion of people with
both first-ever and recurrent ICH, or small sample sizes.
Nearly half of people with CAA-associated ICH in MRI studies did not have superficial
siderosis or severe centrum semiovale enlarged perivascular spaces and nearly one third did
not have lobar microbleeds, underlining the need for further studies to determine which MRI
features–alone or in combination–are most sensitive for CAA-associated ICH. The modified
Boston criteria had limited sensitivity with reasonable specificity in a small hospital-based
cohort of adults with ICH, although not all participants underwent MRI.[33] Nonetheless, this
highlights the requirement for external validation of these criteria to better define their diag-
nostic accuracy.
Differentiating CAA- and non-CAA-associated ICH is important because of potential dif-
ferences in management and prognosis.[2,4] The optimal approach would use an imaging
modality that is available worldwide, given that the greatest global burden of ICH is now in
middle and low income countries.[8] CT, in contrast to MRI and PET, is widely available, has
few contraindications and is frequently used in the acute setting for ICH. CT-based criteria for
CAA-associated lobar ICH may therefore be more widely applicable and practical than those
requiring advanced imaging such as MRI or PET. Our systematic review showed that no such
criteria exist.
Future work should focus on performing well-designed studies to produce accurate diag-
nostic criteria for CAA-associated ICH with low risk of bias. The ideal study design would be a
diagnostic test accuracy study of an unselected, population-based cohort, with a systematic
examination of a pathological reference standard, examining the diagnostic utility of relevant
imaging features, such as subarachnoid and intraventricular extension, irregular ICH border
and multiple simultaneous acute ICHs identified in this review. The imaging features should
clearly and reliably defined, particularly those that are subjective, such as ‘irregular’ or ‘lobu-
lated’ ICH.[39,40] Given the variable assessment of CAA, its patchy distribution with vulnera-
bility to sampling variation[41] and co-existence with other small vessel diseases,[42] a
standard definition of ‘CAA-associated ICH’ is also essential. Pathological and imaging assess-
ment should be blinded, and assessment by multiple raters is required to determine inter-
observer variability.
In conclusion, this systematic review of radio-pathological studies showed that subarach-
noid extension and an irregular border are the most common imaging features of CAA-associ-
ated lobar and cerebellar ICH. However, the diagnostic value of these and other imaging
features needs to be assessed in rigorous diagnostic test accuracy studies. CT-based diagnostic
criteria for CAA-associated ICH would be the most widely applicable, particularly for frail
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patients who cannot tolerate MRI and PET, and in low-middle income countries where
advanced imaging is not available and the greatest global burden of ICH lies now and in the
future.[8]
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S1 Fig. Meta-analysis of the relative risk of imaging features in first-ever vs. recurrent
CAA-associated ICH. n = number of participants with feature, N = denominator, RR = rela-
tive risk, (95% CI) = 95% confidence intervals.
(TIF)
S2 Fig. Meta-analysis of the relative risk of imaging features in people with CAA-associ-
ated ICH and a history of hypertension vs. people without a history of hypertension.
n = number of participants with feature, N = denominator, RR = relative risk, (95% CI) = 95%
confidence intervals.
(TIF)
S3 Fig. Superficial siderosis in CAA-associated ICH—Pooled proportion meta-analysis.
ES = effect size, n = number of participants with superficial siderosis, N = total number with
CAA-associated ICH, (95% CI) = 95% confidence intervals.
(TIF)
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